✦ LIBER ✦

Light-activated antibodies in the fight against primary and metastatic cancer

✍ Scribed by Stephen Thompson; Alexander C. Self; Colin H. Self

Book ID: 113569114
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 492 KB
Volume: 15
Category: Article
ISSN: 1359-6446
DOI: 10.1016/j.drudis.2010.04.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Leveraging Primary Care in the Fight Aga

Leveraging Primary Care in the Fight Against Lung Cancer

✍ Jason L. Sanders; Yolonda L. Colson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Aromatase activity in primary and metast

Aromatase activity in primary and metastatic human breast cancer

✍ Allan Lipton; Steven J. Santner; Richard J. Santen; Harold A. Harvey; Peter D. F 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

Aromatase activity in primary and metast

Aromatase activity in primary and metastatic hunan breast cancer [Poster 43]

✍ Allan Lipton; Steven J. Santner; Richard J. Santen; Harold A. Harvey; Peter D. F 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Creativity and assertiveness in advancin

Creativity and assertiveness in advancing the fight against breast cancer

✍ M. Ziv 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Use of radiolabelled monoclonal antibodi

Use of radiolabelled monoclonal antibodies in patients with primary and metastatic large bowel cancer

✍ S.L. Sergile; D.G. Haller; J.M. Daly 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 793 KB

ChemInform Abstract: New Weapons in the

ChemInform Abstract: New Weapons in the Fight Against Cancer.

✍ I. OJIMA; P.-Y. BOUNAUD; R. J. BERNACKI 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB

New Weapons in the Fight Against Cancer. -Taxane derivatives (I) and (II) exhibit high multidrug resistance reversal activity against drug-resistant breast cancer cells when coadministered with anticancer drugs such as paclitaxel and doxorubicin. Their negligible cytotoxicity makes them attractive c